Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$102.6M
+48.0% from 2023
Prescriptions
7,365
$13,936.24 per claim
Patients
1,124
475 prescribers
Total spending, 2024
$102.7M
$91,303.68 per patient
Medicare prescription drug plans paid $102.6M for Darzalex Faspro in 2024, for 7,365 prescriptions and refills to 1,124 patients (up 48.0% from 2023). The average cost per claim was $13,936.24.
New York had the highest Medicare cost for Darzalex Faspro in 2024: $31.3M for 2,141 claims, followed by California ($15.1M).
Kirtan N Koticha, hematology-oncology in Shreveport, LA, had the highest Medicare cost for Darzalex Faspro in 2024: 178 claims costing $2.9M.
Darzalex Faspro is made by Johnson & Johnson (JNJ), listed in the Medicare spending data as Janssen Biotech.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Kirtan N Koticha Shreveport, LA | Hematology-Oncology | 178 | 30 | $2.9M |
| Sanaullah Khalid Youngstown, OH | Hematology-Oncology | 141 | Under 11 | $1.3M |
| James R Berenson |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 283 | 2,601 | 473 | $42.0M |
| 2023 | 346 | 4,445 | 694 | $69.4M |
| 2024 | 475 | 7,365 | 1,124 | $102.6M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 74 |
| 12 |
| $1.2M |
| Seth A Benkel New City, NY | Hematology-Oncology | 53 | Under 11 | $888K |
| Tarek Elrafei Bronx, NY | Hematology-Oncology | 38 | Under 11 | $817K |
| Carlos A Gadea Orlando, FL | Hematology-Oncology | 38 | Under 11 | $805K |
| Kenneth Blankstein Flemington, NJ | Hematology-Oncology | 51 | Under 11 | $779K |
| Ivette Vigoda Bronx, NY | Hematology-Oncology | 82 | Under 11 | $752K |
| Youram Nassir Los Angeles, CA | Hematology | 36 | Under 11 | $751K |
| Sudhir Hansalia Trinity, FL | Hematology-Oncology | 68 | Under 11 | $745K |
| Maria A Scouros Houston, TX | Hematology-Oncology | 19 | Under 11 | $745K |
| Thomas R Blom Princeton, NJ | Hematology-Oncology | 79 | 11 | $741K |
| Nolyn C Nyatanga Valley Stream, NY | Hematology-Oncology | 64 | Under 11 | $733K |
| Mylene S Go Chester, PA | Hematology-Oncology | 43 | Under 11 | $733K |
| Li-Teh Wu Elmhurst, NY | Medical Oncology | 52 | Under 11 | $725K |
| Abhirami Vivekanandarajah Staten Island, NY | Internal Medicine | 70 | Under 11 | $720K |
| Roger Hakimian Warren, OH | Hematology-Oncology | 75 | Under 11 | $718K |
| Isaac Levy Hollywood, FL | Hematology-Oncology | 40 | Under 11 | $711K |
| Phu N Tran Port St Lucie, FL | Hematology-Oncology | 52 | Under 11 | $710K |
| Ashvini Sengar Gadsden, AL | Hematology-Oncology | 49 | Under 11 | $709K |
| Seetha R Murukutla Staten Island, NY | Hematology-Oncology | 57 | Under 11 | $706K |
| Tina A Khair Gettysburg, PA | Hematology-Oncology | 65 | Under 11 | $679K |
| Norland Ng New York, NY | Hematology-Oncology | 24 | Under 11 | $677K |
| Alfredo E Torres Gonzalez Port Jefferson Station, NY | Hematology-Oncology | 66 | Under 11 | $674K |
| Manish Dhawan Minden, LA | Hematology-Oncology | 35 | Under 11 | $665K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Janssen Biotech JNJ | 7,367 | $102.7M |